ArticleClinical science (London, England : 1979)2026
ZNF827 pleiotropic cardiovascular risk locus involves regulation by nuclear factor-1.
Article in Clinical science (London, England : 1979), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Spontaneous coronary artery dissection (SCAD) is a form of myocardial infarction that predominantly affects middle-aged women, caused by the spontaneous onset of an intramural hematoma leading to heart ischemia. SCAD genetic risk loci, such as the ZNF827 locus on chromosome 4, were previously associated with the risk for coronary artery disease, systolic blood pressure, and ascending aortic diameter variability, but the molecular processes driving these genetic associations are unknown. In the present study, we demonstrated that these genetic associations were colocalized and could all be explained by the intronic common variant rs13128814, which overlapped epigenetic regulatory markers specifically active in vascular smooth muscle cells (SMCs) and fibroblasts. Using reporter assay experiments, we found that the SCAD-risk allele (rs13128814-A) was associated with increased transcriptional activity in A7r5 SMCs. In silico predictions and reporter assays suggested nuclear factor-1 (NF1) transcription factors to preferentially bind to SCAD risk allele. We found that SCAD genetic association colocalized with a ZNF827 eQTL association in artery tissues. Knockdown of ZNF827 in human iPSC-derived SMCs and fibroblasts identified a large number of dysregulated genes enriched in relevant pathways such as macroautophagy and insulin signaling. Our findings support the NF1-dependent rs13128814 effect on the expression of ZNF827 as a potential molecular mechanism underpinning multiple cardiovascular trait genetic risk loci. ZNF827 may act as a broad regulator of gene expression in vascular SMCs and fibroblasts. Further investigation using multiple cell types, organoids, and in vivo models may clarify the implications of ZNF827 in arterial fragility observed in SCAD and other arterial diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.